|

Effect of ınhaler Use on Oral Health in COPD Patients

RECRUITINGN/ASponsored by Çankırı Karatekin University
Actively Recruiting
PhaseN/A
SponsorÇankırı Karatekin University
Started2025-05-30
Est. completion2025-08-30
Eligibility
Age35 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07000604

Summary

The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.

Eligibility

Age: 35 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosed with COPD for at least 6 months,
* Outpatient and inpatient,
* Consent to participate in the research,
* Not under the age of eighteen,
* With a metered dose inhaler (MDI) in treatment,
* No communication barriers,
* No COPD exacerbation and/or respiratory tract infection,
* According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).

Exclusion Criteria:

* Diagnosed with COPD for less than 6 months,
* Refused to participate in the research,
* Treatment without metered dose inhalers (MDIs),
* Uncommunicative,
* Those who withdrew from participating in the study during data collection,
* Not completing the survey,
* COPD exacerbation and/or respiratory tract infection,

Conditions2

COPDChronic Obstructive Pulmonary Disease (COPD)

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.